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Intravenous leiomyomatosis (IVL) is a rare, histologically benign
but biologically aggressive tumor. It should be considered in patients
with a history of uterine ﬁbroids or a pelvic mass accompanied by
right atrial tumor, right heart dysfunction, Budd–Chiari syndrome,
or deep vein thrombosis (Anselmi et al., 2010). Surgical resection is
curative if complete resection is achieved. Unique features of our
case include the gonadal vein origin of the leiomyomas, the extensive
nature of tumor related venous thrombi, and severe intraoperative
coagulopathy resulting in the use of a staged procedure for tumor
resection.
Case report
The patient is a 44 year-old gravida 5, para 5 who presented with
a history of dyspnea and lower extremity edema. Physical exam ﬁnd-
ings included sinus tachycardia, an oxygen saturation of 93% on room
air, and severe lower extremity edema. Chest X-ray showed pulmo-
nary edema. Lower extremity Doppler showed left sided deep venous
thrombi. Computed tomography (CT) demonstrated a solid, 10 cm
mass involving the right uterine cornua and extending into the right
gonadal vein, inferior vena cava (IVC), and right atrium (see Fig. 1).
No peritoneal nodularity or retroperitoneal adenopathy was noted.
CT angiogram detected extensive thrombus in the left common fem-
oral, renal, and hepatic veins, inferior vena cava, and right atrium,
also a large pulmonary artery thrombus. Magnetic resonance imaging
(MRI) conﬁrmed these ﬁndings (see Figs. 2 and 3). Echocardiogram⁎ Corresponding author at: 101 The City Dr. South, Bldg 56, Suite 800, RM 812,
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right atrium extending from the IVC.
Initial treatment included percutaneous thrombectomy and strepto-
kinase thrombolysis, followed by intravenous heparin for treatment of
the extensive thrombi. Subsequently this was converted to lepirudin
after the patient developed heparin induced thrombocytopenia.
A CT guided core needle biopsy demonstrated whorled fascicles of
uniform smooth muscle cells without cellular atypia, mitosis, or ne-
crosis. There was no evidence of malignancy, yet the sample was
the extent of the disease and the uncertain pathology, the ability to
achieve surgical cure was unclear. However during the course of our
workup, the patient's hemodynamic status began to deteriorate,
resulting in symptoms of severe pulmonary edema and hypotension
due to cardiogenic shock. Therefore the decision was made by gyne-
cologic oncology, vascular, and cardiothoracic surgery, to attempt
complete resection of the mass and venous thrombi which was
accomplished in a two-staged procedure.
First intra-atrial and perihepatic IVC tumor extraction was per-
formed via a median sternotomy and midline laparotomy. After com-
plete dissection of the infrahepatic IVC tumor, including the bilateral
gonadal veins, right heart bypass was initiated and the intra-atrial por-
tion of the tumor was removed. Adherence of the tumor to the cardiac
and caval walls resulted in a prolonged and difﬁcult resection with sig-
niﬁcant blood loss. The combination of prolonged operating time, hem-
orrhage, hypovolemia and hepatic dysfunction subsequently lead to
signiﬁcant coagulopathy. This was managed with massive transfusion
of blood products and packing of the abdominal and retroperitoneal
cavity. Given the patient's hemodynamic instability, total abdominal
hysterectomy and bilateral salpingooophorectomy was delayed for
48 h, during which time ﬁnal pathology of the intracardiac mass
revealed benign leiomyoma (see Fig. 3). At the second operation, ﬁnd-
ings included multiple uterine leiomyoma with extension into the
right cornua and right gonadal vein. The patient recovered well from
her surgery and given the benign ﬁnal pathology and the completeness
of her resection, no further adjuvant therapy was indicated.Comment
Intravascular leiomyomatosis is a rare tumor characterized by nodu-
lar masses of histologically benign smooth muscle growing within
veins. It may arise from the uterus, ovaries, or kidneys (Anselmi et al.,
2010). It usually spreads through the uterine or ovarian veins, and can
progress into the caval vein and right heart (Nam et al., 2003). There
are two main theories about the etiology of these tumors (Norris and
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Fig. 1. Left: Large right pleural effusion, solid mass in the right atrium. Right: Thrombo-
sis of the hepatic veins, signs of liver congestion, and enhancing solid mass is shown in
the intrahepatic inferior vena cava.
Fig. 3. Portions of inferior vena cava tumor correspond to area of the inferior vena cava
mass on pre-operative CT scan. Gross specimen on left measures 6×3×4 cm.
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The second is that the primary uterine leiomyoma spreads into adjacent
venous structures by direct extension.
The most common presenting symptom among reported cases is
shortness of breath and dyspnea on exertion, though pelvic pain
and abnormal uterine bleeding was also sometimes noted. Other
common symptoms include pleuritic chest pain, pedal edema,
abdominal distension, or syncope (Nam et al., 2003). The tumor can
be misdiagnosed as thrombus or primary cardiac tumor such as a
myxoma. Imaging such as echocardiography, chest and abdominal
CT and MRI should be performed pre-operatively to determine the
extent of the disease (Nam et al., 2003).
Distinguishing between intravascular leiomyoma and leiomyo-
sarcoma can be challenging. There have been three reports of
leiomyosarcoma in the literature with a similar clinical presenta-
tion (Coard and Fletcher, 2002; McDonald et al., 2007; Moorjani et
al., 2005). All three cases were also associated with tumor emboli
and venous thromboembolism. No signs or symptoms, tumor
markers, or imaging could reliably differentiate between the two
entities. The diagnosis of each is based on histological ﬁndings.
Leiomyosarcoma is deﬁned by coagulative tumor necrosis, severe
cytological atypia, and greater than 10 mitotic ﬁgures per 10 high
power ﬁelds. However, even with these clear deﬁnitions, sampling
error can confound the results of any histological analysis. There-
fore only a large tissue sample can conclusively exclude the diagno-
sis of malignancy. While the accuracy of CT guided biopsy for the
diagnosis of abdominal masses is on the order of 90% (Steil et al.,
2009), in the case of leiomyosarcoma, sampling error and the rarityCervix
Fundus with mass
Fig. 2. Left: Large exophytic mass arising from superior, lateral aspect of the uterus
growing superiorly into the right gonadal vein and IVC. Right: Large enhancing
exophytic mass arising from superior aspect of uterus.of the disease decrease this test's negative predictive value substan-
tially. In our case, CT guided biopsy was requested by a co-
consulting service. Though the biopsy and ﬁnal surgical pathology
proved to be concordant, as a general rule, differentiating
leiomyoma from leiomyosarcoma must be done using a large spec-
imen to overcome the problem of sampling error. Therefore core
needle biopsy plays little role in establishing a pre-operative
diagnosis.
Complete resection is curative, therefore every effort should bemade
to achieve this. Complete resection can be accomplished via a two stage
procedure involving resection of the abdominal/pelvic and intrathoracic
components in two separate operations, or in a single-stage operation
using cardiopulmonary or right heart bypass. Our case was done in two
stages due to the complications of coagulopathy and hemorrhage during
the intrathoracic portion of the procedure. Our patient's presentation
with extensive venous thrombi requiring anticoagulation prior to sur-
gery further complicated her care and to our knowledge has not been
reported elsewhere.
In cases of incomplete resection or tumor recurrence, use of antiestro-
gens such as tamoxifen has been considered but their efﬁcacy remains
controversial (Nam et al., 2003). Animal models for uterine leiomyoma
have provided valuable preclinical evidence for the usefulness of SERMs.
Palomba et al. investigated the effects of raloxifene in postmenopausal
women with uterine leiomyoma and found that tumor size was signiﬁ-
cantly reduced after 12 months of treatment, with relatively few side ef-
fects (Palomba et al., 2001; Palomba et al., 2002). Recurrence rates as high
as 30% have been reported following incomplete resection (Ahmed et al.,
2004), and can occur as early as 6 months and as late as 15 years after ini-
tial presentation (Anselmi et al., 2010). A standard follow up regimen has
yet to be established.
In summary, intravenous leiomyomatosis is a rare, histologically be-
nign, but biologically aggressive tumor. There are no diagnostic tools
that can reliably distinguish it from leiomyosarcoma prior to surgery.
Complete resection is curative, but antiestrogens have also been shown
to stabilize and decrease tumor burden when surgical resection cannot
be achieved.Conﬂict of interest statement
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